4.7 Article

Association between Change in Body Composition and Change in Inflammatory Markers: An 11-Year Follow-Up in the Whitehall II Study

期刊

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
卷 95, 期 12, 页码 5370-5374

出版社

ENDOCRINE SOC
DOI: 10.1210/jc.2010-0730

关键词

-

资金

  1. Medical Research Council
  2. British Heart Foundation
  3. Wellcome Trust
  4. Health and Safety Executive
  5. Department of Health
  6. Agency for Health Care Policy Research, United Kingdom
  7. John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health
  8. National Heart, Lung, and Blood Institute [R01HL036310]
  9. National Institute on Aging [R01AG013196, R01AG034454]
  10. National Institutes of Health, Bethesda, Maryland
  11. Academy of Finland, Finland
  12. BUPA Foundation, United Kingdom
  13. European Science Foundation
  14. Swedish Council for Working Life and Social Research [2009-1450]
  15. UK Medical Research Council
  16. Chief Scientist Office at the Scottish Government Health Directorates
  17. Academy of Finland
  18. British Heart Foundation [RG/07/008/23674] Funding Source: researchfish
  19. Medical Research Council [G19/35, G8802774, G0902037, G0100222] Funding Source: researchfish
  20. MRC [G0902037] Funding Source: UKRI

向作者/读者索取更多资源

Context: Obesity is associated with low-grade inflammation, but the long-term effects of weight change on inflammation are unknown. Objective: The aim was to examine the association of change in weight, body mass index (BMI), and waist circumference with change in C-reactive protein (CRP) and IL-6 and to assess whether this association is modified by baseline obesity status. Design and Setting: The design was a prospective cohort study among civil servants (the Whitehall II Study, UK). We used data from two clinical screenings carried out in 1991-1993 and 2002-2004 (mean follow-up, 11.3 yr). Participants: We studied 2496 men and 1026 women [mean age, 49.4 (SD = 6.0) yr at baseline] with measurements on inflammatory markers and anthropometry at both baseline and follow-up. Main Outcome Measures: We measured change in serum CRP and IL-6 during follow-up. Results: The mean increases in CRP and IL-6 were 0.08 [95% confidence interval (Cl), 0.07-0.09] mg/liter and 0.04 (95% Cl, 0.03-0.05) pg/ml per 1-kg increase in body weight during follow-up. Study members with a BMI less than 25 kg/m(2) at baseline had an average increase in CRP of 0.06 (95% Cl, 0.05-0.08) mg/liter per 1-kg increase in body weight, whereas the increase in those who were overweight (25 <= BMI < 30 kg/m(2)) and obese (BMI >= 30 kg/m(2)) was greater: 0.08 (95% Cl, 0.06-0.09) mg/liter and 0.11 (95% Cl, 0.07-0.14) mg/liter, respectively (P value for interaction = 0.002). Similar patterns were observed for changes in BMI and waist circumference. Conclusions: Those who were overweight or obese at baseline had a greater absolute increase in CRP per unit increase in weight, BMI, and waist circumference than people who were normal weight. (J Clin Endocrinol Metab 95: 5370-5374, 2010)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据